TRAM Educational Conference March 15 2013 Anne Arundel Medical Center Clarification of Data Items and Coding Practices Objectives Discuss various data items and increase awareness of accurate coding practices by Maryland Registrars ID: 616216
Download Presentation The PPT/PDF document "Clarification of Data Items and Coding P..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Clarification of Data Items and Coding Practices
TRAM Educational Conference
March 15, 2013
Anne Arundel Medical CenterSlide2
Clarification of Data Items and Coding Practices
Objectives:
Discuss various data items and increase awareness of accurate coding practices by Maryland Registrars.
Discuss the importance of accurate coding and understanding of data items presented.
Tips on working smarter not harder.
Update from the MCRSlide3
Type Reporting Source
Codes
Hospital inpatient
Radiation Treatment Centers or Medical Oncology Centers
Laboratory only
Physician’s office/private medical practitioner
Nursing/convalescent home/hospice
Autopsy only
Death certificate only
Other hospital outpatient units/surgery centersSlide4
Type Reporting Source
This data item is intended to indicate the completeness of information available to the abstractor.
Code in the following priority order: 1, 2, 8, 4, 3, 5, 6, 7
Sources with ‘2’ usually have complete information on the cancer diagnosis, staging, and treatment. Slide5
Type Reporting Source
Codes
Hospital inpatient
Radiation Treatment Centers or Medical Oncology Centers
Laboratory only – use only if the cases are considered lab only.
Physician’s office/private medical practitioner –
do not use unless you have an agreement w/ physicians’
office
to report for them.
Nursing/convalescent home/hospice
Autopsy only
Death certificate only
Other hospital outpatient units/surgery centersSlide6
Type Reporting Source
Sources coded with ‘8’ would include, but not limited to, outpatient surgery and nuclear medicine services. A physician’s office that calls itself a surgery center should be coded as a physician’s office.
Surgery centers are equipped to perform surgical procedures under general anesthesia. Slide7
Race
If you are entering multiple race codes and one includes ’01’ for white, placement of ’
01’ should be last
in the sequence
Reminder that Hawaiian trumps all other races.Slide8
Dx
Date prior to 1/1/2004
NO CS Data Fields Required
Leave all CS data fields blank
From CS tumor size to
SSF25Slide9
LymphoVascular
Invasion
Use code
8
for cases that have no microscopic examination of a primary specimen and for the following primary sites:
Hodgkin and Non-Hodgkin Lymphoma
Leukemia
Hematopoietic and
reticuloendothelial
disorders
MDS including refractory anemia and refractory
cytopenia
Myeloproliferative disordersSlide10
Summary Stage 2000
Heme
/Lymphoid neoplasms should be coded to
7
to reflect systemic disease.Slide11
CS Mets at Dx
= 00
CS Mets Brain =
0
CS Mets Bone
=
0
CS Mets Liver
=
0
CS Mets Lung
=
0
If Date of Diagnosis is > 2004/1/1 otherwise leave blankSlide12
Lung Cancer SSF2
You MUST have histologic examination of the pleura to code this field. This can only be accomplished with a resection. A biopsy doesn’t provide enough tissue to establish pleural involvement. Imaging doesn’t provide the histologic confirmation.
Use code
998
when there is no histologic examination of the pleura.Slide13
Lung Cancer SSF2
Note 2
: Code results as stated on the pathology report. Code 998 if no histologic examination of pleura to assess pleural layer invasion.
Note 3
: If pleural/elastic layer invasion (PL) is not mentioned on the pathology
report from a resection,
code 999. Slide14
Lung Cancer SSF2
Note
4
: An FNA is not a histologic specimen and is not adequate to assess pleural layer invasion. If only an FNA is available, use code 998.
Note 5
: Metastasis to the pleura, that is pleural tumor foci or nodules separate from direct invasion, are coded in CS Mets at
Dx
(code 24). Slide15
Breast Cancer – SSF 15
CS Site-Specific Factor
15 - HER2
: Summary Result of Testing
This variable is based on CS Site-Specific Factors 9, 11, 13, and 14
.
SSF 15 should reflect the test interpretation of either IHC, FISH, CISH or other/unknown test.
If SSF9 = 020 then SSF15 should also = 020 Slide16
Breast Cancer – SSF 15
CS Site-Specific Factor
15 - HER2
: Summary Result of Testing
If both an IHC and a gene-amplification test (FISH or CISH) are performed, record the result of the gene-amplification test in this field.
However
, if the gene-amplification test is given first and the result is borderline or equivocal and an IHC test is done to clarify these equivocal results, code the result of the IHC test. Slide17
Breast Cancer – SSF 15
CS Site-Specific Factor 15 - HER2: Summary Result of Testing
If
the results of one test are available, and it is known that a second test is performed but the results are not available, use code 997. Slide18
Prostate Cancer Tumor Size/Ext Eval
Note
7: For CS Extension - Clinical Extension codes 200 - 240 without prostatectomy assign
CS Tumor Size/Ext
Eval
code
0
as these extension codes are based on physical examination and/or imaging only and NOT biopsy. Slide19
Cause of Death
Code 0000 if the patient is alive
Code 7777 if the patient is deceased and the death certificate is not available.
You may use this field to reflect cause of death at your facility. We overwrite when we conduct death follow-back activities. Slide20
ICD Revision Number
Be sure to use the correct ICD revision number for coding Cause of Death. Mortality codes from the death certificate are coded in ICD-
10
, otherwise, this field should be coded to either:
0
– patient is alive
9
– ICD-
9
-CMSlide21
Melanoma – Diagnostic vs. Surgical
A skin biopsy of any technique (shave, punch, incisional) that shows GROSS residual disease is coded in Surgical Diagnostic and Staging Procedure as 02.
A biopsy with positive margins invisible to the eye, but visible by microscope is coded as an excisional biopsy, Primary Surgery codes 20 – 27.
Re-excisions are coded to 30 – 33. Slide22
Melanoma – Diagnostic vs. Surgical
Do not code excisional biopsies with clear or microscopic margins in the Surgical Diagnostic/Staging Procedures field.
Code in Surgery Primary SiteSlide23
Melanoma – SSF3
In-situ Melanoma – SSF 3 should = 005
005 Clinically negative lymph node metastasis
AND
No
pathologic examination performed
Or unknown if pathologic examination performed
Or nodes negative on pathologic examinationSlide24
TURB – Diagnostic vs. Surgical
A diagnostic TURB is considered surgery and should not be coded in the Diagnostic/Staging Procedures.
Use code 27 in the Surgery Primary Site to record TURB’sSlide25
BCG Therapy
BCG Therapy for Bladder cancer should be coded in both the Surgery Primary Site field and the BRM field.
10
Local tumor destruction, NOS
11
Photodynamic therapy (PDT)
12
Electrocautery
; fulguration (includes use of hot forceps for tumor
destruction
)
13
Cryosurgery
14
Laser
15
Intravesical therapy
16
Bacillus
Calmette
-Guerin (BCG) or other immunotherapySlide26
BCG Therapy
Typically, BCG is administered weekly for 6 weeks. Another 6-week course may be administered if a repeat
cystoscopy reveals
tumor persistence or recurrence. Recent evidence indicates that maintenance therapy with a weekly treatment for 3 weeks every 6 months for 1-3 years may provide more lasting results. Periodic bladder biopsies are usually necessary to assess response.Slide27
BCG Therapy
From the
Canswer
Forum:
If
a patient with a urothelial bladder primary has a TURB followed immediately by BCG how would we code treatment. Would we assign surgery as 27 and
immnunotherapy
as 01 or would we assign two surgical procedures and give one a code of 16 and the other a code of 27 and then also code immunotherapy as 01. Could you give some background as to why we code BCG and
intravesicle
chemo in the surgery codes?Slide28
BCG Therapy
This question was answered by Jerri Linn Phillips who is manager of NCDB and editor of FORDS.
"
As to the final question, years ago when I asked why the BCG instillation code was in surgery, I was told that the surgeons on the manual’s update team wanted it there
.”
The purpose of the primary site surgery codes is to describe what was removed from the patient. BCG instillation is grouped with the
‘10s’
numeric series (no pathology) because it does not itself involve tissue removal though a surgeon and surgical prep may be part of the procedure. The BCG itself should be coded in
immunotherapy,
so that information is retrievable under any circumstances. Only if no other surgery was performed should the BCG instillation code be
used.Slide29
BCG Therapy
Therefore, if any surgery with a code 20 or above also applies, it should be coded for surgery and the applicable
BRM
code
assigned
. If a hospital performs multiple primary site surgeries, each successively is coded so that it includes all tissue previously surgically removed (BCG does not do its thing surgically). See the first full paragraph at the top of page 22 in FORDS: Revised for 2011. The code given when the last surgery was performed will include the earlier surgery, and therefore it will include the TURB even if it is followed by the BCG. That is why 16 is not coded when something 20 or higher has been coded. This is because we want to know what was removed from the patient; the codes were not designed to capture series of multiple intervening surgeries.Slide30
Adenocarcinoma – intestinal type
Adenocarcinoma, intestinal type (
8144)
is
a form of stomach cancer.
Do
not
use this
code when the tumor arises
in
the colon
.Slide31
Working smarter not harder Slide32
Working smarter not harder
Social Media – Facebook
I am a
manager of a medium to large sized registry (1400+ cases a year)
in
the process of training two non-CTRs (no other CTRs except myself). One is 6 months into the job the other is
1.5
yrs. They are fairly independent at this point and are producing abstracts that need to be QA'd for accuracy and completeness. I have been doing 100% QA but am finding it
more
difficult to keep up with the volume. Can anyone offer some ways to cut down the time it is taking to QA (we
re-abstract
for the most part) without jeopardizing the importance of receiving meaningful feedback that lends to effective learning. Any suggestions are welcome!Slide33
Working smarter not harder
RUN REPORTS!!!
Take a day and set up and save some QA reports that can be used to check the quality of individual abstractors data.
For example:
Query on one abstractors initials and see if they’re coding histology correctly for papillary carcinoma of the thyroid.
8050 vs. 8260 for C739Slide34
Working smarter not harder
Benign Brain tumors
Check meningiomas to confirm behavior code of ‘0’ and sequence number 60.
Lung Cancer
Check SSF 2 against the surgery codes. If surgery codes are less than a wedge resection, then SSF 2 should = 998Slide35
Working smarter not harder
Use
GenEdits
Create a file with cases from each abstractor, individually.
Run that file through
GenEdits
and see what the results are.
Be sure to log or maintain some documentation of your QA activities!!
You can manage 10% re-abstractingSlide36
Working smarter not harder
You can manage 10%
re-abstracting if you’re running some type of edits reports and documenting the findings.
By having the abstractors correct their own work, it’s a great learning tool. Slide37
Clarification of Data Items and Coding Practices
QUESTIONS??Slide38
Updates from MCR
Passwords
Stronger passwords will be requested on and after April 1, 2013
8 – 20 characters
Must contain at least one digit
Must contain at least one upper and one lower case letter
Must contain at least one special character (!@#$%)Slide39
Updates from MCR
Disease Indices
Reinstatement of annual submission of disease indices
WHY???
Completeness
Death Follow-backSlide40
Updates from MCR
Disease Indices
Submission by March 1st each year (since we’ve missed the deadline this year, please submit by May 1
st
)
Reminders will be sent via email
Call us if this will be delayed or if assistance is neededSlide41
Updates from MCR
Disease Indices
Submission by May 1 each year
Reminders will be sent via email
Call us if this will be delayed or if assistance is neededSlide42
Updates from MCR
Disease Indices
Format
Excel - .
xls
or .
xlsx
CSV – comma separated valueSlide43
Updates from MCR
Disease Indices
MUST include all elements outlined in the instructions.
MUST include Jan – Dec of the previous year.Slide44
Updates from MCR
QUESTIONS??